论文部分内容阅读
目的观察血栓通与神经妥乐平联合治疗糖尿病周围神经病变的临床疗效。方法按照随机数字表法将90例糖尿病周围神经病变患者随机分为观察组(45例)及对照组(45例),对照组患者在常规降糖治疗的基础上给予血栓通治疗,观察组在对照组的基础上加用神经妥乐平。两组疗程皆为2周。结果观察组总有效率(93.33%),显著高于对照组(57.78%),具有统计学意义(P<0.05);治疗后,观察组的神经传导速度显著高于对照组,存在统计学意义(P<0.05)。结论血栓通与神经妥乐平联合治疗糖尿病周围神经病变具有较好的疗效,且安全可行,值得临床借鉴。
Objective To observe the clinical efficacy of Xueshuantong combined with neurotropin in the treatment of diabetic peripheral neuropathy. Methods Ninety patients with diabetic peripheral neuropathy were randomly divided into observation group (45 cases) and control group (45 cases) according to random number table method. Patients in control group were given Xueshuantong treatment on the basis of routine hypoglycemic treatment. The control group based on the addition of neurotropin. Both groups were treated for 2 weeks. Results The total effective rate (93.33%) in observation group was significantly higher than that in control group (57.78%), with statistical significance (P <0.05). After treatment, the nerve conduction velocity in observation group was significantly higher than that in control group (P <0.05). Conclusion Xueshuantong and neurotropin combined treatment of diabetic peripheral neuropathy has a good effect, and safe and feasible, it is worth learning from.